Xanthomas Planus (Plane Xanthoma)

Overview

Xanthomas planus, also known as plane xanthoma, is a skin disorder characterized by flat or slightly raised, yellow‑orange plaques that most commonly appear on the neck, upper trunk, and flexural areas. The lesions are collections of lipid‑laden macrophages (foamy histiocytes) within the dermis. While the skin changes themselves are benign, they frequently signal an underlying lipid metabolism disorder or systemic disease, making recognition important for early diagnosis and treatment.

Both sexes can be affected, but a slight male predominance has been reported in several case series (approximately 55‑60% of patients). The condition is rare, with prevalence estimates ranging from 0.02% to 0.1% in the general population, but it is considerably more common among individuals with severe dyslipidemias or certain hematologic disorders.^[1][2]

Symptoms

Plane xanthomas are primarily a cutaneous manifestation. The following list covers the typical features and associated symptoms:

• Flat or slightly raised plaques – Soft, well‑defined, yellow‑orange lesions that are usually 0.5–5 cm in diameter.
• Location – Most often seen on the:
  • Neck (especially the posterior cervical region)
  • Upper back and shoulders
  • Chest (particularly the supraclavicular area)
  • Axillae and other flexural sites
• Texture – Painless, non‑pruritic, and may feel slightly velvety or waxy.
• Color – Ranges from pale yellow to deep orange; occasionally a reddish hue appears if inflammation is present.
• Growth pattern – Lesions develop slowly over months to years; they may coalesce into larger patches.
• Associated systemic signs – Because plane xanthomas often reflect lipid abnormalities, patients may also have:
  • Family history of high cholesterol or early‑onset cardiovascular disease
  • Symptoms of hyperlipidemia (e.g., fatty streaks on the cornea, known as corneal arcus)
  • Signs of underlying disease (e.g., jaundice with liver disease, fatigue with monoclonal gammopathy)

Causes and Risk Factors

Plane xanthomas are not a primary disease; they are a cutaneous marker of disrupted lipid handling. The most common underlying etiologies include:

1. Primary Lipid Disorders

• Familial hypercholesterolemia (FH) – Autosomal dominant mutation in the LDL‑R, APOB, or PCSK9 genes. Up to 30% of FH patients develop plane xanthomas.^[3]
• Familial combined hyperlipidemia – Elevated LDL‑C and triglycerides.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia) – Presence of apoE2/E2 genotype; classically produces palmar xanthomas and plane xanthomas.

2. Secondary Causes

• Hepatitis C and other chronic liver diseases – Impaired lipoprotein clearance.
• Nephrotic syndrome – Protein loss leads to increased hepatic lipoprotein production.
• Endocrine disorders – Hypothyroidism, diabetes mellitus.
• Hematologic malignancies – Particularly multiple myeloma, Waldenström macroglobulinemia, and other monoclonal gammopathies; the abnormal proteins can alter lipid transport.

3. Medication‑Induced

• High‑dose glucocorticoids, retinoids, and certain antiretroviral agents can raise triglycerides and precipitate xanthoma formation.

Risk Factors

• Positive family history of dyslipidemia or premature coronary artery disease.
• Age: lesions most often appear in the second to fourth decade but can occur at any age.
• Male sex (slight predominance).
• Smoking and sedentary lifestyle – exacerbate underlying lipid abnormalities.
• Uncontrolled diabetes or hypothyroidism.

Diagnosis

Making a diagnosis of plane xanthoma involves a combination of clinical examination, laboratory testing, and occasionally skin biopsy.

1. Clinical Evaluation

• Visual inspection of characteristic yellow‑orange, flat plaques.
• Distribution assessment – lesions over the neck, trunk, and flexures are typical.
• Detailed medical and family history focused on lipid disorders, liver/kidney disease, and malignancy.

2. Laboratory Tests

3. Skin Biopsy (when needed)

In atypical cases, a 4‑mm punch biopsy is performed. Histology shows dermal collections of foamy macrophages (lipid‑laden histiocytes) without significant epidermal involvement. Special stains (Oil Red O) highlight neutral lipids.

4. Imaging (rare)

When a systemic disease is suspected, imaging such as abdominal ultrasound (for hepatomegaly) or echocardiography (to assess atherosclerotic burden) may be ordered.

Treatment Options

The cornerstone of therapy is correcting the underlying lipid abnormality. Dermatologic treatments are adjunctive for cosmetic concerns.

1. Lipid‑Lowering Medications

• Statins (e.g., atorvastatin, rosuvastatin) – First‑line for LDL‑C reduction; can improve or resolve plane xanthomas in 6‑12 months.^[4]
• Ezetimibe – Blocks intestinal cholesterol absorption; helpful when statins alone are insufficient.
• PCSK9 inhibitors (alirocumab, evolocumab) – Powerful LDL‑C lowering; indicated for FH patients who do not achieve target levels with statins.
• Fibrates (gemfibrozil, fenofibrate) – Primarily lower triglycerides; useful in type III hyperlipoproteinemia.
• Bile‑acid sequestrants (cholestyramine) – Adjunct for modest LDL‑C reduction.

2. Treatment of Secondary Causes

• Antiviral therapy for chronic hepatitis C.
• Immunosuppression adjustment in nephrotic syndrome.
• Levothyroxine replacement for hypothyroidism.
• Oncologic therapy (chemotherapy, targeted agents) for underlying hematologic malignancies.

3. Dermatologic Procedures (Cosmetic)

• Laser therapy – Q‑switched Nd:YAG or CO₂ lasers can reduce pigmented lipid deposits; requires multiple sessions.
• Chemical peels – Trichloroacetic acid (TCA) or glycolic acid can improve surface appearance but do not address the underlying lipid load.
• Intralesional corticosteroids – Occasionally used for inflamed lesions, though effect is limited.
• Excisional surgery – Reserved for isolated, resistant plaques.

4. Lifestyle Modifications

• Heart‑healthy diet – Emphasize soluble fiber, plant sterols, omega‑3 fatty acids; limit saturated fat, trans fat, and simple sugars.
• Regular physical activity – At least 150 minutes of moderate aerobic exercise per week improves lipid profile.
• Weight management – Achieving a BMI < 25 kg/m² reduces LDL‑C and triglycerides.
• Smoking cessation – Decreases cardiovascular risk and may hasten xanthoma regression.

Living with Xanthomas Planus (Plane Xanthoma)

While the lesions themselves are not harmful, they can affect self‑esteem and signal systemic disease. Below are practical tips for day‑to‑day management:

• Adhere to medication regimen – Set daily alarms or use pill organizers.
• Track lipid numbers – Keep a log of fasting lipid panels; share results with your clinician every 3–6 months.
• Skin care – Use gentle, fragrance‑free moisturizers; avoid excessive rubbing of plaques.
• Sun protection – UV exposure may darken lesions; apply SPF 30+ sunscreen daily.
• Support networks – Join patient groups for familial hypercholesterolemia or lipid disorders for emotional support.
• Regular medical follow‑up – Annual review with a lipid specialist or endocrinologist; sooner if new symptoms arise.

Prevention

Because plane xanthomas are usually secondary to another condition, prevention focuses on maintaining normal lipid metabolism:

• Screen family members for hyperlipidemia if a relative has FH or plane xanthomas.
• Adopt a Mediterranean‑style diet rich in fruits, vegetables, whole grains, nuts, and oily fish.
• Limit alcohol intake (< 2 drinks/day for men, < 1 for women) as excessive alcohol raises triglycerides.
• Control blood glucose and blood pressure – both influence lipid levels.
• Stay up‑to‑date with vaccinations (e.g., hepatitis B) to reduce liver disease risk.

Complications

If the underlying cause remains untreated, several serious complications may develop:

• Accelerated atherosclerosis – Elevated LDL‑C and triglycerides promote plaque formation, increasing risk of myocardial infarction and stroke.
• Pancreatitis – Particularly with severe hypertriglyceridemia (> 1,000 mg/dL).
• Liver dysfunction – Fatty liver disease can progress to cirrhosis.
• Renal disease progression – Nephrotic syndrome can lead to chronic kidney disease.
• Psychosocial impact – Disfigurement may cause depression or anxiety.

When to Seek Emergency Care

Sources: [1] Mayo Clinic. “Xanthoma.” https://www.mayoclinic.org/diseases-conditions/xanthoma/diagnosis-treatment/drc-20374445 (accessed 2024). [2] National Lipid Association. “Familial Hypercholesterolemia.” https://www.lipid.org (2023). [3] Nordestgaard BG et al. “Familial hypercholesterolaemia is underdiagnosed and undertreated in general practice.” European Heart Journal. 2022. [4] Robinson JG et al. “Statin therapy and regression of cutaneous xanthomas.” Cleveland Clinic Journal of Medicine. 2021.